128 related articles for article (PubMed ID: 10505549)
1. Minimal residual disease in breast cancer.
Kvalheim G; Naume B; Nesland JM
Cancer Metastasis Rev; 1999; 18(1):101-8. PubMed ID: 10505549
[TBL] [Abstract][Full Text] [Related]
2. Detection of occult tumour cells in bone marrow and blood in breast cancer patients--methods and clinical significance.
Kvalheim G
Acta Oncol; 1996; 35 Suppl 8():13-8. PubMed ID: 9073044
[TBL] [Abstract][Full Text] [Related]
3. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
Diel IJ; Solomayer EF; Bastert G
Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
[TBL] [Abstract][Full Text] [Related]
4. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
[TBL] [Abstract][Full Text] [Related]
5. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
[TBL] [Abstract][Full Text] [Related]
9. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of minimal residual disease in bone marrow and blood in cancer patients--methods and clinical implications.
Kvalheim G
Acta Oncol; 1998; 37(5):455-62. PubMed ID: 9831374
[TBL] [Abstract][Full Text] [Related]
11. [Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].
Banyś M; Krawczyk N; Becker S; Becker-Pergola G; Banyś J; Krawczyk Z; Wallwiener D; Fehm T
Ginekol Pol; 2012 Aug; 83(8):590-7. PubMed ID: 23342882
[TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
[TBL] [Abstract][Full Text] [Related]
13. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
[TBL] [Abstract][Full Text] [Related]
15. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products.
Zhong XY; Kaul S; Diel I; Eichler A; Bastert G
J Cancer Res Clin Oncol; 1999; 125(5):286-91. PubMed ID: 10359133
[TBL] [Abstract][Full Text] [Related]
16. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.
Vannucchi AM; Bosi A; Glinz S; Pacini P; Linari S; Saccardi R; Alterini R; Rigacci L; Guidi S; Lombardini L; Longo G; Mariani MP; Rossi-Ferrini P
Br J Haematol; 1998 Dec; 103(3):610-7. PubMed ID: 9858208
[TBL] [Abstract][Full Text] [Related]
18. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
[TBL] [Abstract][Full Text] [Related]
19. [Minimal residual disease in breast carcinoma].
Janků F; Novotný J; Vedralová J; Kleibl Z; Matous B; Petruzelka L
Cas Lek Cesk; 2002 Aug; 141(17):546-50. PubMed ID: 12404958
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA.
Ikeda N; Miyoshi Y; Motomura K; Inaji H; Koyama H; Noguchi S
Jpn J Cancer Res; 2000 Sep; 91(9):918-24. PubMed ID: 11011120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
